Reports Q4 revenue $2.33B, consensus $2.26B. "Quest had another strong year in 2022, with base business revenues growing more than 6% in the fourth quarter, and 5% for the full year," said Jim Davis, CEO and president. "COVID-19 testing revenues declined as expected but still exceeded $1.4 billion in 2022."
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DGX:
- QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2023
- Agilent, Quest team to extend access to Resolution ctDx FIRST NGS test
- Quest Diagnostics initiated with an In Line at Evercore ISI
- Quest Diagnostics price target raised to $154 from $143 at Baird
- Doctors gain confidence in new Alzheimer’s blood tests, Bloomberg reports